Matthew Coffey

Matthew Coffey discloses dealings in Oncolytics Biotech Inc. to SEDI. The record holds 10 filings, for trades running from 22 May 2018 to 29 January 2025.

The open-market record is one-sided, with 6 purchases worth €34k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 option exercises.

In size, the median ticket on the buying side is €4,261. No cluster: in 6 purchases, no other insider of the company bought within 30 days.

The latest filing, published on 29 January 2025, reports an option exercise in Oncolytics Biotech Inc. The clock since the last published purchase (15 June 2022) now reads 1,595 days. The median gap between trade and publication is zero days: most filings appear on the same day. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.